Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Jul;39(7):1472–1479. doi: 10.1128/aac.39.7.1472

Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testing.

P C Fuchs 1, A L Barry 1, D L Sewell 1
PMCID: PMC162765  PMID: 7492088

Abstract

The in vitro antimicrobial activity of an oral penem, WY-49605, was compared with those of six other oral antimicrobial agents against 598 bacterial isolates representing 51 different species. WY-49605 exhibited good activity against most gram-positive bacteria and members of the family Enterobacteriaceae. It had little activity against nonfermenting gram-negative bacilli, Enterobacter spp., Serratia spp., enterococci, Staphylococcus haemolyticus, and methicillin-resistant Staphylococcus aureus. Its activity was unaffected by the beta-lactamases of Neisseria gonorrhoeae, Haemophilus influenzae, and staphylococci. Disk diffusion susceptibility tests were performed with 5-, 10-, 15-, and 30-micrograms WY-49605 disks. The 5-micrograms disk is recommended, with tentative breakpoints of > or = 16 mm for susceptibility (MIC, < or = 2.0 microgram/ml) and < or = 12 mm for resistance (MIC, > or = 8.0 micrograms/ml).

Full Text

The Full Text of this article is available as a PDF (231.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergan T., da Fonseca J. Comparative antibacterial activity of the penem ALP 201. Chemotherapy. 1991;37(6):413–419. doi: 10.1159/000238888. [DOI] [PubMed] [Google Scholar]
  2. Nishino T., Maeda Y., Ohtsu E., Koizuka S., Nishihara T., Adachi H., Okamoto K., Ishiguro M. Studies on penem antibiotics. II. In vitro activity of SUN5555, a new oral penem. J Antibiot (Tokyo) 1989 Jun;42(6):977–988. doi: 10.7164/antibiotics.42.977. [DOI] [PubMed] [Google Scholar]
  3. Nord C. E., Lindmark A., Persson I. Susceptibility of anaerobic bacteria to ALP 201. Antimicrob Agents Chemother. 1989 Dec;33(12):2137–2139. doi: 10.1128/aac.33.12.2137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Rylander M., Nord C. E., Norrby S. R. Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria. Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):919–924. doi: 10.1007/BF01963784. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES